Skip to main content
. 2020 Sep 3;12(9):2492. doi: 10.3390/cancers12092492
ACSS2 acyl-coenzyme A synthetase short-chain family member 2
Akt protein kinase B
BPTES bis-2-(5-phenylacetoamido-1,3,4- thiadiazol-2-yl)-ethyl sulphide
CDK4/6 cyclin-dependent kinase 4 and 6
CPT1A carnitine palmitoyltransferase 1A
CST Cell Signaling Technology
DAB 3:3′-diaminobenzidine
DMFS Distant metastasis-free survival
DMSO dimethyl sulfoxide
ECL enhanced chemiluminescence
EGFR epidermal growth factor receptor
FA fatty acid
FASN fatty acid synthase
FBS foetal bovine serum
FFPE formalin-fixed paraffin-embedded
G6PDH glucose-6-phosphate dehydrogenase
GAC glutaminase C
GAPDH glyceraldehyde 3-phosphate dehydrogenase
GLUT1 glucose transporter 1
GLS glutaminase
HER2 human epidermal growth factor receptor 2
HK2 hexokinase 2
HR hormone receptor
HRP horseradish peroxidase
IHC immunohistochemistry
KGA kidney type glutaminase
LDHA lactate dehydrogenase A
LDHB lactate dehydrogenase B
MCT monocarboxylate transporter
mTOR mammalian target of rapamycin
OS overall survival
OXPHOS oxidative phosphorylation
PARP poly (ADP-ribose) polymerase
PD-1 programmed cell death protein 1
PD-L1 programmed death-ligand 1
PI3K phosphatidylinositol 3-kinase
PI3KCA phosphatidylinositol 3-kinase catalytic subunit A
PKM2 pyruvate kinase 2
PVDF polyvinylidene difluoride
RR relative risk
S6K1 ribosomal protein S6 kinase beta-1
SRB sulforhodamine B
SREBP1 sterol regulatory element-binding protein 1
TCA tricarboxylic acid
TNBC triple-negative breast cancer
VEGF vascular endothelial growth factor
β-F1-ATPase β-F1-adenosine triphosphate synthase